| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:e51.)
© 2003 American Heart Association, Inc.
Research Reports |
From Stroke Service (P.J.K., J.P.K., M.B., K.L.F.) and Amino Acid Laboratory (V.E.S., R.M.), Department of Neurology, and Biostatistics Center (H.L.), Massachusetts General Hospital and Harvard Medical School, Boston.
Reprint requests to Dr P.J. Kelly, Stroke Service, Department of Neurology, VBK 802, Massachusetts General Hospital, Fruit St, Boston, MA 02114. E-mail pjkelly{at}partners.org
Background and Purpose The introduction of cereal grain folic acid fortification in 1998 has reduced homocyst(e)ine (tHcy) concentrations in the US population. We performed a case-control study to determine the risk of stroke and transient ischemic attack (TIA) associated with tHcy and low vitamin status in a postfortification US sample.
Methods Consecutive cases with new ischemic stroke/TIA were compared with matched controls. Fasting tHcy, folate, pyridoxal 5'-phosphate (PLP), B12, and MTHFR 677C
T genotype were measured.
Results Mean PLP was significantly lower in cases than controls (39.97 versus 84.1 nmol/L, P<0.0001). After stroke risk factors were controlled for, a strong independent association was present between stroke/TIA and low PLP (adjusted odds ratio [OR], 4.6; 95% CI, 1.4 to 15.1; P<0.001) but not elevated tHcy (OR, 0.92; 95% CI, 0.4 to 2.1).
Conclusions Low B6 but not tHcy was strongly associated with cerebrovascular disease in this postfortification, folate-replete sample.
Key Words: cerebrovascular disorders homocyst(e)ine pyridoxine risk factors
This article has been cited by other articles:
![]() |
E. T Aasheim, D. Hofso, J. Hjelmesaeth, K. I Birkeland, and T. Bohmer Vitamin status in morbidly obese patients: a cross-sectional study Am. J. Clinical Nutrition, February 1, 2008; 87(2): 362 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dierkes, C. Weikert, K. Klipstein-Grobusch, S. Westphal, C. Luley, M. Mohlig, J. Spranger, and H. Boeing Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort Am. J. Clinical Nutrition, July 1, 2007; 86(1): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Lima, S. R. Davis, A. D. Mackey, J. B. Scheer, J. Williamson, and J. F. Gregory III Vitamin B-6 Deficiency Suppresses the Hepatic Transsulfuration Pathway but Increases Glutathione Concentration in Rats Fed AIN-76A or AIN-93G Diets J. Nutr., August 1, 2006; 136(8): 2141 - 2147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. MacKenzie, E. J. Wiltshire, R. Gent, C. Hirte, L. Piotto, and J. J. Couper Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus Pediatrics, July 1, 2006; 118(1): 242 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Midttun, S. Hustad, E. Solheim, J. Schneede, and P. M. Ueland Multianalyte Quantification of Vitamin B6 and B2 Species in the Nanomolar Range in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., July 1, 2005; 51(7): 1206 - 1216. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |